临床药师糖尿病慢病管理模式的构建和成效评价

马明华; 年华; 刘霞; 田薇薇; 冯轶杉; 余自成

doi:10.3969/j.issn.1006-0111.201903015

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿，请务必投稿前电话或邮箱咨询。联系电话：021-81871323，邮箱：yxsjzzs@163.com。敬请谅解，谢谢配合！

《药学实践与服务》编辑部

免责声明

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用，如收到邮件声称是编辑部X编辑，要求加作者微信的，请谨防财产损失！编辑部用于作者校稿时微信绑定的邮件是通过yxsjzzs@163.com发送的，标题是《药学实践与服务》XML数字出版服务微信绑定，请区分开！

临床药师糖尿病慢病管理模式的构建和成效评价

马明华, 年华, 刘霞, 田薇薇, 冯轶杉, 余自成

文章导航 > 药学实践与服务 > 2020 > 38(1): 91-96

马明华, 年华, 刘霞, 田薇薇, 冯轶杉, 余自成. 临床药师糖尿病慢病管理模式的构建和成效评价[J]. 药学实践与服务, 2020, 38(1): 91-96. doi: 10.3969/j.issn.1006-0111.201903015

引用本文:

MA Minghua, NIAN Hua, LIU Xia, TIAN Weiwei, FENG Yishan, YU Zicheng. Establishment and effectiveness evaluation of clinical pharmacist diabetes chronic disease management model[J]. Journal of Pharmaceutical Practice and Service, 2020, 38(1): 91-96. doi: 10.3969/j.issn.1006-0111.201903015

Citation:

MA Minghua, NIAN Hua, LIU Xia, TIAN Weiwei, FENG Yishan, YU Zicheng. Establishment and effectiveness evaluation of clinical pharmacist diabetes chronic disease management model[J]. Journal of Pharmaceutical Practice and Service, 2020, 38(1): 91-96. doi: 10.3969/j.issn.1006-0111.201903015

临床药师糖尿病慢病管理模式的构建和成效评价

doi: 10.3969/j.issn.1006-0111.201903015

1.
同济大学附属杨浦医院药学部, 上海 200090
2.
上海中医药大学附属岳阳中西医结合医院药学部, 上海 200437

基金项目: 同济大学附属杨浦医院基金（Se1201633）

Establishment and effectiveness evaluation of clinical pharmacist diabetes chronic disease management model

1.
Department of Pharmacy, Yangpu Hospital, Tongji University, Shanghai 200090, China
2.
Department of Pharmacy, Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

摘要: 目的评价临床药师开展糖尿病患者药学监护和管理的效果。方法选取门诊406例成年糖尿病患者作为研究对象，由临床药师分发调查问卷，并定期做用药指导和健康教育等药学干预，通过对干预前后患者糖尿病用药相关知识的掌握情况、血糖及糖化血红蛋白的达标情况、治疗依从性、非预约门诊、急诊、住院情况等比较，并进行统计分析。结果药学干预后患者对糖尿病及用药相关知识的掌握情况、治疗依从性、血糖及糖化血红蛋白达标情况均优于干预前，P<0.01；非预约门诊、急诊情况也优于干预前，P<0.05，有显著性差异。结论临床药师开展糖尿病慢病管理，构建临床药师主导的慢病管理模式，有助于促进规范化治疗，提高患者依从性，促进合理化用药，达到控制血糖、减少并发症的目的。
- 临床药师 /
- 糖尿病 /
- 慢病管理 /
- 成效评价
Abstract: Objective To evaluate the role of clinical pharmacists on the pharmacological monitoring and management of diabetic patients. Methods 406 adult outpatients with diabetes in outpatient were selected as research object. The patients were given the questionnaire and intervened with diabetes education and management by the clinical pharmacist regularly. The patient's knowledge of the diabetes medication before and after intervention, blood glucose and glycosylated hemoglobin values, treatment compliance, non-reserved outpatient visit, emergency, hospitalization, etc. were compared and statistically analyzed. Results After pharmacy intervention, the patients' knowledge of diabetes and drug-related information, treatment compliance, blood glucose and glycosylated hemoglobin were better than before intervention, P<0.01. Non-reserved outpatient visits and emergency cases were better than before intervention, P<0.05. There are significant differences. Conclusion Clinical pharmacists carry out diabetes chronic disease management and build a clinical pharmacist-led chronic disease management model, which helps to promote standardized treatment, improve patient compliance, promote rationalized medication, achieve the goal of controlling blood sugar and reduce complications.
- clinical pharmacist /
- diabetes /
- chronic disease management /
- effectiveness evaluation

[1]	肖小丹. 首个动态血糖检测系统被美国FDA批准使用[J]. 首都食品与医药, 2017, 24(13):64
[2]	中华糖尿病杂志指南与共识编写委员会. 中国糖尿病药物注射技术指南(2016年版)[J]. 中国糖尿病杂志, 2017, 9(2):79-105
[3]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1):4-67
[4]	王翠捷, 廖国杭, 罗振, 等. 临床药师参与社区慢性病管理对2型糖尿病患者用药依从性的影响[J]. 中国药物经济学, 2017, 12(4):153-155
[5]	Chinese Society of Endocrinology. 预混胰岛素临床应用专家共识(2016年版)[J]. 药品评价, 2016, 13(9):5-11
[6]	马明华, 薛冬梅, 田薇薇, 等. 临床药师开展哮喘规范化管理的成效分析[J]. 中国药师, 2014, 17(7):1194-1197
[7]	张静, 赵丽云, 于冬梅. 老年糖尿病的流行病学研究进展[J]. 世界最新医学信息文摘(电子版), 2016, 16(80):34-35
[8]	MILOSAVLJEVIC A, ASPDEN T, HARRISON J. Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: a systematic review[J]. Int J Pharm Pract,2018,26(5):387-397
[9]	PRUDENCIO J, CUTLER T, ROBERTS S, et al. The effect of clinical pharmacist-led comprehensive medication management on chronic disease state goal attainment in a patient-centered medical home[J]. J Manag Care Spec Pharm,2018,24(5):423-429

[1]	舒飞, 孙蕊, 宋凯, 张元林, 闫家铭, 舒丽芯. 粉-液双室袋产品的综合评价 . 药学实践与服务, 2025, 43(2): 92-96. doi: 10.12206/j.issn.2097-2024.202312009
[2]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[3]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2025, 43(3): 143-150. doi: 10.12206/j.issn.2097-2024.202312027
[4]	彭莹, 刘欣, 聂依文, 王歆荷, 年华, 朱建勇. 三种狼毒乙醇提取物对咪喹莫特诱导的银屑病小鼠防治作用研究 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202406029
[5]	曹金发, 钟玲, 何苗, 田泾. 1例炎症性肠病合并心房颤动患者的用药分析与监护 . 药学实践与服务, 2025, 43(10): 525-528. doi: 10.12206/j.issn.2097-2024.202403004
[6]	邵尉, 袁妮, 刘叶, 于飞, 柳莹, 王峰. 丙戊酸钠与左乙拉西坦治疗儿童癫痫病的成本-效果分析 . 药学实践与服务, 2025, 43(8): 1-5. doi: 10.12206/j.issn.2097-2024.202408046
[7]	柯刚, 董清科, 肖世容, 龚茜, 李荣, 汪代杰. 基于网络药理学探讨参苓白术散治疗肿瘤恶病质的作用机制 . 药学实践与服务, 2025, 43(5): 242-250. doi: 10.12206/j.issn.2097-2024.202208115
[8]	续畅, 周心娜, 漆璐, 王瑜, 王兴河. 基于文献计量学对我国临床试验用药品管理研究现状的数据挖掘 . 药学实践与服务, 2025, 43(8): 1-6. doi: 10.12206/j.issn.2097-2024.202404050
[9]	杨志晖, 蔡华丹, 徐方楚, 刘园, 袁海龙. 临床药师参与人粒细胞刺激因子致弥漫性肺泡出血的病例分析 . 药学实践与服务, 2025, 43(11): 567-571. doi: 10.12206/j.issn.2097-2024.202506021
[10]	王兰英, 陆高峰, 袁梅娟, 李卫玲, 罗盈怡, 徐峰. 社区药学门诊服务对2型糖尿病患者的管理效果分析 . 药学实践与服务, 2025, 43(7): 357-361. doi: 10.12206/j.issn.2097-2024.202407002
[11]	常伟, 顾申勇. 综合用药管理在糖尿病患者管理中的实践 . 药学实践与服务, 2025, 43(10): 514-518, 524. doi: 10.12206/j.issn.2097-2024.202402037
[12]	杨凤艳, 张月, 陈恩贤, 缪雪蓉, 魏凯. 瑞马唑仑临床应用研究进展 . 药学实践与服务, 2024, 42(9): 365-374. doi: 10.12206/j.issn.2097-2024.202405026
[13]	温瑞睿, 许龙, 朱文静, 杨建伟. 浅谈国外药师主导开展戒烟服务的作用与挑战 . 药学实践与服务, 2024, 42(12): 537-541, 548. doi: 10.12206/j.issn.2097-2024.202408054
[14]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(12): 512-519. doi: 10.12206/j.issn.2097-2024.202401050
[15]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
[16]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[17]	徐飞, 刘盈, 殷佳, 诸国樑, 练鲁英. 上海某三级公立医院药品管理内部控制评价实践研究 . 药学实践与服务, 2024, 42(12): 542-548. doi: 10.12206/j.issn.2097-2024.202402003
[18]	刘依秦, 王超群, 邱娇娜. 胆宁片预处理在糖尿病患者结肠镜检查前的应用效果分析 . 药学实践与服务, 2024, 42(9): 407-410. doi: 10.12206/j.issn.2097-2024.202407037
[19]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
[20]	徐飞, 陈瑾, 鲁育含, 李志勇. 肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023

点击查看大图

计量

文章访问数: 7020
HTML全文浏览量: 917
PDF下载量: 2745
被引次数: 0

临床药师糖尿病慢病管理模式的构建和成效评价

doi: 10.3969/j.issn.1006-0111.201903015

1. 同济大学附属杨浦医院药学部, 上海 200090

2. 上海中医药大学附属岳阳中西医结合医院药学部, 上海 200437

基金项目: 同济大学附属杨浦医院基金（Se1201633）

收稿日期: 2019-03-04
修回日期: 2019-11-08

关键词:

临床药师 /

糖尿病 /

慢病管理 /

成效评价

摘要: 目的评价临床药师开展糖尿病患者药学监护和管理的效果。方法选取门诊406例成年糖尿病患者作为研究对象，由临床药师分发调查问卷，并定期做用药指导和健康教育等药学干预，通过对干预前后患者糖尿病用药相关知识的掌握情况、血糖及糖化血红蛋白的达标情况、治疗依从性、非预约门诊、急诊、住院情况等比较，并进行统计分析。结果药学干预后患者对糖尿病及用药相关知识的掌握情况、治疗依从性、血糖及糖化血红蛋白达标情况均优于干预前，P<0.01；非预约门诊、急诊情况也优于干预前，P<0.05，有显著性差异。结论临床药师开展糖尿病慢病管理，构建临床药师主导的慢病管理模式，有助于促进规范化治疗，提高患者依从性，促进合理化用药，达到控制血糖、减少并发症的目的。

English Abstract

Establishment and effectiveness evaluation of clinical pharmacist diabetes chronic disease management model

1. Department of Pharmacy, Yangpu Hospital, Tongji University, Shanghai 200090, China

2. Department of Pharmacy, Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

Received Date: 2019-03-04
Rev Recd Date: 2019-11-08

Keywords:

Abstract: Objective To evaluate the role of clinical pharmacists on the pharmacological monitoring and management of diabetic patients. Methods 406 adult outpatients with diabetes in outpatient were selected as research object. The patients were given the questionnaire and intervened with diabetes education and management by the clinical pharmacist regularly. The patient's knowledge of the diabetes medication before and after intervention, blood glucose and glycosylated hemoglobin values, treatment compliance, non-reserved outpatient visit, emergency, hospitalization, etc. were compared and statistically analyzed. Results After pharmacy intervention, the patients' knowledge of diabetes and drug-related information, treatment compliance, blood glucose and glycosylated hemoglobin were better than before intervention, P<0.01. Non-reserved outpatient visits and emergency cases were better than before intervention, P<0.05. There are significant differences. Conclusion Clinical pharmacists carry out diabetes chronic disease management and build a clinical pharmacist-led chronic disease management model, which helps to promote standardized treatment, improve patient compliance, promote rationalized medication, achieve the goal of controlling blood sugar and reduce complications.

引用本文:

Citation:

MA Minghua, NIAN Hua, LIU Xia, TIAN Weiwei, FENG Yishan, YU Zicheng. Establishment and effectiveness evaluation of clinical pharmacist diabetes chronic disease management model[J]. Journal of Pharmaceutical Practice and Service, 2020, 38(1): 91-96. doi: 10.3969/j.issn.1006-0111.201903015